13 In this review, we will examine their pharmacology, evidence supporting their use in HF, mechanisms of cardiovascular protection, safety profile, and current guidelines and recommendations
Rather than viewing these as competing approaches, the evidence suggests they function best as complementary strategies in maintaining cellular redox balance
One-on-one consultations with clinical pharmacy specialists are also available
Summary: What the Evidence Actually Shows 13
The most commonly prescribed GLP-1 medications include: Semaglutide Available as Ozempic (semaglutide) for diabetes and Wegovy (semaglutide) for weight management Tirzepatide Sold as Mounjaro (tirzepatide) for diabetes and Zepbound (tirzepatide) for weight loss Liraglutide Available as Victoza (liraglutide) for diabetes and Saxenda (liraglutide) for weight management Clinical trials demonstrate significant benefits for these medications
In the brainstem and spinal cord, glycine functions as a primary inhibitory neurotransmitter